AnalyzeDirect Folaron M, Kalmuk J, Lockwood J, Frangou C, Vokes J, Turowski SG, Merzianu M, Rigual NR, Sullivan-Nasca M, Kuriakose MA, Hicks WL, Jr., Singh AK, Seshadri M. Vascular priming enhances chemotherapeutic efficacy against head and neck cancer. Oral Oncol. September 2013;49(9):893-902.
Full Text – Open Access
Publication Date
September 2013
How Analyze was Used
“All images were processed using LAS AF Lite (Leica, Germany) and Analyze 7.0 (AnalyzeDirect, Overland Park, KS).”
Keywords
Angiogenesis
Antineoplastic Agents/therapeutic use
Head and Neck Neoplasms/blood supply/drug therapy
Head and Neck Squamous Cell Carcinoma
Humans
Magnetic Resonance Imaging
Microscopy, Fluorescence
Vascular Disrupting Agents
Vascular Targeting
Xanthones/therapeutic use
Xenograft Model Antitumor Assays
Author Affiliation(s)
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, US. (MF, JK, JL, JV, SGT, MS)
Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, US. (CF)
Department of Pathology & Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, US. (MM)
Department of Head & Neck/Plastic and Reconstructive Surgery, Roswell Park Cancer Institute, Buffalo, NY 14263, US. (NRR, MAK, WLH, MS)
Department of Dentistry & Maxillofacial Prosthetics, Roswell Park Cancer Institute, Buffalo, NY 14263, US. (MS-N, MS)
Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, US. (AKS)
ID# 56
Tags: Angiogenesis, Antineoplastic Agents/therapeutic use, Fluorescence Microscopy, Head and Neck Neoplasms/blood supply/drug therapy, Head and Neck Squamous Cell Carcinoma, Humans, Magnetic Resonance Imaging, Vascular Disrupting Agents, Vascular Targeting, Xanthones/therapeutic use, Xenograft Model Antitumor Assays